Ischemic preconditioning (IPC) is blocked by diabetes mellitus through activation of glycogen synthase kinase 3-beta (GSK3β), which is also a critical mediator for several pharmacological agents conferring cardioprotection [21]. Here, GSK3B is linked to diabetes mellitus.